ID   HeLa SilenciX XPA
AC   CVCL_KU25
SY   XPA HeLa SilenciX
DR   Wikidata; Q54882672
RX   PubMed=16179499;
WW   http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00015.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; 12814; XPA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 7
//
RX   PubMed=16179499; DOI=10.1158/1541-7786.MCR-05-0044;
RA   Biard D.S.F., Despras E., Sarasin A., Angulo J.F.;
RT   "Development of new EBV-based vectors for stable expression of small
RT   interfering RNA to mimick human syndromes: application to NER gene
RT   silencing.";
RL   Mol. Cancer Res. 3:519-529(2005).
//